You are here: Home: CACU 2 | 2008: Faculty Disclosures
CONTENT VALIDATION AND DISCLOSURES
Research To Practice (RTP) is committed to providing its participants with high-quality, unbiased and
state-of-the-art education. We assess potential conflicts of interest with faculty, planners and managers
of CME activities. Real or apparent conflicts of interest are identified and resolved through a conflict of
interest resolution process. In addition, all activity content is reviewed by both a member of the RTP
scientific staff and an external, independent physician reviewer for fair balance, scientific objectivity of
studies referenced and patient care recommendations.
FACULTY — Dr Winer had no real or apparent conflicts of interest to disclose. The following faculty (and
their spouses/partners) reported real or apparent conflicts of interest, which have been resolved through
a conflict of interest resolution process: Dr George — Advisory Committee: Pfizer Inc, Sanofi-Aventis,
Wyeth; Consulting Agreements: Genentech BioOncology, GlaxoSmithKline, Novartis Pharmaceuticals
Corporation, Pfizer Inc, Sanofi-Aventis, Wyeth; Paid Research: Amgen Inc, Bristol-Myers Squibb
Company, GlaxoSmithKline, Novartis Pharmaceuticals Corporation, Pfizer Inc, Wyeth; Speakers
Bureau: Pfizer Inc, Sanofi-Aventis. Dr Kim — Advisory Committee: AstraZeneca Pharmaceuticals
LP, ImClone Systems Incorporated; Paid Research: AstraZeneca Pharmaceuticals LP, Eli Lilly and
Company, Genentech BioOncology, ImClone Systems Incorporated, OSI Pharmaceuticals Inc, Sanofi-
Aventis; Speakers Bureau: Eli Lilly and Company, Genentech BioOncology, Sanofi-Aventis. Dr Leonard — Advisory Committee: Celgene Corporation, Cephalon Inc, Millennium Pharmaceuticals, The Takeda
Oncology Company, Novartis Pharmaceuticals Corporation, Pharmion Corporation, Wyeth; Consulting
Agreements: Biogen Idec, Genentech BioOncology, GlaxoSmithKline, Millennium Pharmaceuticals,
The Takeda Oncology Company, Novartis Pharmaceuticals Corporation, Pharmion Corporation, Wyeth;
Speakers Bureau: GlaxoSmithKline, Millennium Pharmaceuticals, The Takeda Oncology Company.
Dr Venook — Advisory Committee: Amgen Inc, ImClone Systems Incorporated; Grant Funding: Genentech BioOncology; Paid Research: Novartis Pharmaceuticals Corporation, Pfizer Inc.
RESEARCH TO PRACTICE STAFF AND EXTERNAL REVIEWERS — The scientific staff and reviewers
for Research To Practice have no real or apparent conflicts of interest to disclose.
This educational activity contains discussion of published and/or investigational uses of agents that are
not indicated by the Food and Drug Administration. Research To Practice does not recommend the use
of any agent outside of the labeled indications. Please refer to the official prescribing information for each
product for discussion of approved indications, contraindications and warnings. The opinions expressed
are those of the presenters and are not to be construed as those of the publisher or grantors.
|